Correlation Between Microsoft and Arch Therapeutics
Can any of the company-specific risk be diversified away by investing in both Microsoft and Arch Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Arch Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Arch Therapeutics, you can compare the effects of market volatilities on Microsoft and Arch Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Arch Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Arch Therapeutics.
Diversification Opportunities for Microsoft and Arch Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Arch is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Arch Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Arch Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and Arch Therapeutics go up and down completely randomly.
Pair Corralation between Microsoft and Arch Therapeutics
Given the investment horizon of 90 days Microsoft is expected to generate 0.23 times more return on investment than Arch Therapeutics. However, Microsoft is 4.32 times less risky than Arch Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Arch Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 42,785 in Microsoft on November 5, 2024 and sell it today you would lose (1,279) from holding Microsoft or give up 2.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Microsoft vs. Arch Therapeutics
Performance |
| Timeline |
| Microsoft |
| Arch Therapeutics |
Microsoft and Arch Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Arch Therapeutics
The main advantage of trading using opposite Microsoft and Arch Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Arch Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Therapeutics will offset losses from the drop in Arch Therapeutics' long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Adobe Systems Incorporated | Microsoft vs. Crowdstrike Holdings |
| Arch Therapeutics vs. biOasis Technologies | Arch Therapeutics vs. Antibe Therapeutics | Arch Therapeutics vs. Awakn Life Sciences | Arch Therapeutics vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |